Results 11 to 20 of about 37,898 (281)

Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction. [PDF]

open access: yesPLoS ONE, 2016
Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection fraction (HFrEF) may emerge from recent advances in high-throughput urinary proteomics.
Kasper Rossing   +10 more
doaj   +10 more sources

Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention [PDF]

open access: goldFrontiers in Cardiovascular Medicine, 2022
BackgroundChronic kidney disease (CKD) is very common in patients who are at a high risk of developing incident heart failure with reduced ejection fraction (HFrEF).
Wenguang Lai   +36 more
doaj   +2 more sources

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF [PDF]

open access: goldFrontiers in Cardiovascular Medicine, 2023
Heart failure (HF) is a chronic and progressive syndrome affecting worldwide billions of patients. Exercise intolerance and early fatigue are hallmarks of HF patients either with a reduced (HFrEF) or a preserved (HFpEF) ejection fraction. Alterations of the skeletal muscle contribute to exercise intolerance in HF.
Norman Mangner   +4 more
openaire   +4 more sources

Sacubitril/valsartan reduces atrial fibrillation and supraventricular arrhythmias in patients with HFrEF and remote monitoring: preliminary data from the SAVE THE RHYTHM [PDF]

open access: bronze, 2020
Sacubitril/valsartan, the first combined angiotensin receptor-neprilysin inhibitor, has demonstrated a significant benefit compared to angiotensin inhibitor in decreasing ventricular arrhythmias and appropriate implantable cardioverter ...
F. Guerra   +12 more
semanticscholar   +2 more sources

Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs [PDF]

open access: goldCells, 2019
Circulating microRNAs offer attractive potential as epigenetic disease biomarkers by virtue of their biological stability and ready accessibility in liquid biopsies.
Yei-Tsung Chen   +3 more
semanticscholar   +2 more sources

Differences in biomarkers and molecular pathways according to age for patients with HFrEF. [PDF]

open access: bronzeCardiovascular Research, 2020
AIMS Elderly patients with heart failure with reduced ejection fraction (HFrEF) have worse prognosis and less often receive guideline-recommended therapies.
J. Ferreira   +17 more
semanticscholar   +2 more sources

Optimizing Foundational Therapies in Patients With HFrEF

open access: goldJACC: Basic to Translational Science, 2022
Abhinav Sharma   +7 more
semanticscholar   +2 more sources

Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]

open access: yes, 2017
OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M   +16 more
core   +20 more sources

A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program [PDF]

open access: green, 2016
Theodore Murphy   +9 more
openalex   +4 more sources

Home - About - Disclaimer - Privacy